Search results for the GEO ID: GSE21252
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM531248
GPL96
Daudi + 5 µM 5-aza-dC (6 days) + 625 nM TSA (24 h), rep1 Daudi, A/T treatment cell line: Daudi cell type: B-cell lymphoma cells treatment: 5-aza-dC, trichostatin A Daudi_A/T-treated _1
GSM531249
GPL96
Daudi + 5 µM 5-aza-dC (6 days) + 625 nM TSA (24 h), rep2 Daudi, A/T treatment cell line: Daudi cell type: B-cell lymphoma cells treatment: 5-aza-dC, trichostatin A Daudi_A/T-treated_2
GSM531250
GPL96
Daudi untreated, rep1 Daudi, untreated cell line: Daudi cell type: B-cell lymphoma cells treatment: untreated Daudi_untreated_1
GSM531251
GPL96
Daudi untreated, rep2 Daudi, untreated cell line: Daudi cell type: B-cell lymphoma cells treatment: untreated Daudi_untreated_2
GSM531252
GPL96
Namalwa + 5 µM 5-aza-dC (6 days) + 625 nM TSA (24 h), rep1 Namalwa, A/T treatment cell line: Namalwa cell type: B-cell lymphoma cells treatment: 5-aza-dC, trichostatin A Namalwa_A/T-treated_1
GSM531253
GPL96
Namalwa + 5 µM 5-aza-dC (6 days) + 625 nM TSA (24 h), rep2 Namalwa, A/T treatment cell line: Namalwa cell type: B-cell lymphoma cells treatment: 5-aza-dC, trichostatin A Namalwa_A/T-treated_2
GSM531254
GPL96
Namalwa untreated, rep1 Namalwa, untreated cell line: Namalwa cell type: B-cell lymphoma cells treatment: untreated Namalwa_untreated_1
GSM531255
GPL96
Namalwa untreated, rep2 Namalwa, untreated cell line: Namalwa cell type: B-cell lymphoma cells treatment: untreated Namalwa_untreated_2
GSM531256
GPL96
Raji + 5 µM 5-aza-dC (6 days) + 625 nM TSA (24 h), rep1 Raji, A/T treatment cell line: Raji cell type: B-cell lymphoma cells treatment: 5-aza-dC, trichostatin A Raji_A/T-treated_1
GSM531257
GPL96
Raji + 5 µM 5-aza-dC (6 days) + 625 nM TSA (24 h), rep2 Raji, A/T treatment cell line: Raji cell type: B-cell lymphoma cells treatment: 5-aza-dC, trichostatin A Raji_A/T-treated_2
GSM531258
GPL96
Raji untreated, rep1 Raji, untreated cell line: Raji cell type: B-cell lymphoma cells treatment: untreated Raji_untreated_1
GSM531259
GPL96
Raji untreated, rep2 Raji, untreated cell line: Raji cell type: B-cell lymphoma cells treatment: untreated Raji_untreated_2
GSM531260
GPL96
SU-DHL4 + 5 µM 5-aza-dC (6 days) + 625 nM TSA (24 h), rep1 SU-DHL4, A/T treatment cell line: SU-DHL4 cell type: B-cell lymphoma cells treatment: 5-aza-dC, trichostatin A SU-DHL4_A/T-treated_1
GSM531261
GPL96
SU-DHL4 + 5 µM 5-aza-dC (6 days) + 625 nM TSA (24 h), rep2 SU-DHL4, A/T treatment cell line: SU-DHL4 cell type: B-cell lymphoma cells treatment: 5-aza-dC, trichostatin A SU-DHL4_A/T-treated_2
GSM531262
GPL96
SU-DHL4 untreated, rep1 SU-DHL4, untreated cell line: SU-DHL4 cell type: B-cell lymphoma cells treatment: untreated SU-DHL4_untreated_1
GSM531263
GPL96
SU-DHL4 untreated, rep2 SU-DHL4, untreated cell line: SU-DHL4 cell type: B-cell lymphoma cells treatment: untreated SU-DHL4_untreated_2
GSM531264
GPL96
SU-DHL6 + 5 µM 5-aza-dC (6 days) + 625 nM TSA (24 h), rep1 SU-DHL6, A/T treatment cell line: SU-DHL6 cell type: B-cell lymphoma cells treatment: 5-aza-dC, trichostatin A SU-DHL6_A/T-treated_1
GSM531265
GPL96
SU-DHL6 + 5 µM 5-aza-dC (6 days) + 625 nM TSA (24 h), rep2 SU-DHL6, A/T treatment cell line: SU-DHL6 cell type: B-cell lymphoma cells treatment: 5-aza-dC, trichostatin A SU-DHL6_A/T-treated_2
GSM531266
GPL96
SU-DHL6 untreated, rep1 SU-DHL6, untreated cell line: SU-DHL6 cell type: B-cell lymphoma cells treatment: untreated SU-DHL6_untreated_1
GSM531267
GPL96
SU-DHL6 untreated, rep2 SU-DHL6, untreated cell line: SU-DHL6 cell type: B-cell lymphoma cells treatment: untreated SU-DHL6_untreated_2
GSM531268
GPL96
HT + 5 µM 5-aza-dC (6 days) + 625 nM TSA (24 h) HT, A/T treatment cell line: HT cell type: B-cell lymphoma cells treatment: 5-aza-dC, trichostatin A HT_A/T_treated
GSM531269
GPL96
HT HT, untreated cell line: HT cell type: B-cell lymphoma cells treatment: untreated HT_untreated
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes